ondansetron has been researched along with HIV Infections in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolli, V | 1 |
| Addula, M | 1 |
| Gabriel, CM | 1 |
| Minor, JR | 1 |
| Vogel, S | 1 |
| Piscitelli, SC | 1 |
2 other studies available for ondansetron and HIV Infections
| Article | Year |
|---|---|
Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
Topics: Adult; Anti-Anxiety Agents; Antiretroviral Therapy, Highly Active; Anxiety Disorders; Citalopram; Dr | 2019 |
Supportive care during aldesleukin therapy for patients infected with human immunodeficiency virus.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antiemetics; Female; Fever; HIV Infections; Humans; | 1997 |